logo-loader

4D Pharma begins trading shares on the Nasdaq following merger with Longevity

Published: 11:42 23 Mar 2021 GMT

4D pharma PLC (LON: DDDD) (NASDAQ:LBPS) CEO Duncan Peyton tells Proactive the group passed a “transformational milestone” following the completion of its merger with investment vehicle Longevity Acquisition Corporation. Peyton says the transaction provides the UK group with a quote on the tech- and biotech-focused NASDAQ stock market and has raised $40M in capital, putting 4D in a 'great position' to advance its oncology and Parkinson's Disease programs.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 55 minutes ago